Real-time enrollment status for this congenital adrenal hyperplasia clinical trial
Current Status
Recruiting
Checked: October 24, 2026 at 10:58 PM UTC
| NCT Number | NCT07536269 |
| Recruiting Status | Recruiting |
| Condition | Congenital Adrenal Hyperplasia |
| Phase | PHASE2 |
| Target Enrollment | 20 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Neurocrine Switzerland GmbH |
| Last Updated on CT.gov | September 16, 2026 (Sep 16, 2026) |
As of October 24, 2026: Clinical trial NCT07536269 is currently recruiting participants. This phase2 study for congenital adrenal hyperplasia is actively seeking new participants at 11 locations across the United States. The study is sponsored by Neurocrine Switzerland GmbH. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07536269 is actively recruiting participants as of October 24, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07536269 was last updated Sep 16, 2026 (September 16, 2026). HelloStudys verifies this status automatically.